← Back to Search

Diagnostic Test

Aegis CDM Test for Chronic Disease

N/A

Waitlist Available

Research Sponsored by Qure Healthcare, LLC

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up [19 months]

Awards & highlights

Study Summary

This trial looks at how primary care docs diagnose & treat common medical conditions, to improve patient care.

Who is the study for?

This trial is for board-certified primary care physicians in the U.S., specifically in Family Medicine or Internal Medicine, with a practice size of at least 40 patients per week. They should treat common conditions like heart disease and diabetes, have internet access, and their patients must have signed HIPAA authorizations.Check my eligibility

What is being tested?

The study is evaluating the Aegis CDM Test along with educational materials to see how they impact doctors' clinical decisions regarding chronic diseases such as metabolic syndrome and cardiometabolic issues.See study design

What are the potential side effects?

Since this trial involves an assessment tool (Aegis CDM Test) and educational materials rather than a medical treatment, there are no direct side effects for patients. The focus is on physician decision-making.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ [19 months]

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~[19 months]

This trial's timeline: 3 weeks for screening, Varies for treatment, and [19 months] for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Chart abstraction measured variation in clinical decisions

Chart abstraction measured variation in quality of care

Chart abstraction measured variation in quantity of care

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Educational Materials and Test AccessExperimental Treatment1 Intervention

These participants will complete their online simulations and treat their real-life patients with access to educational materials and the Aegis test results. Investigators will compare intervention participants' clinical recommendations to those in the control arm.

Group II: Control GroupActive Control1 Intervention

These participants will complete their online simulations and treat their real-life patients without access to the Aegis test.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Aegis CDM Test and Educational Materials

2022

N/A

~120

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Qure Healthcare, LLCLead Sponsor

21 Previous Clinical Trials

3,841 Total Patients Enrolled

1 Trials studying Cardiometabolic Syndrome

249 Patients Enrolled for Cardiometabolic Syndrome

Media Library

Aegis CDM Test (Diagnostic Test) Clinical Trial Eligibility Overview. Trial Name: NCT05910684 — N/A

Cardiometabolic Syndrome Research Study Groups: Educational Materials and Test Access, Control Group

Cardiometabolic Syndrome Clinical Trial 2023: Aegis CDM Test Highlights & Side Effects. Trial Name: NCT05910684 — N/A

Aegis CDM Test (Diagnostic Test) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05910684 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities for candidates to join this clinical trial presently?

"As found on clinicaltrials.gov, this medical research is no longer enrolling participants; the trial began being advertised on July 19th 2022 and was last updated June 15th 2023. Fortunately, there are still 269 other trials actively recruiting patients right now."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study

2022. "Establishing Clinical Utility Evidence for Chronic Disease Management Testing Patient Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05910684.